A detailed history of Fox Run Management, L.L.C. transactions in Dexcom Inc stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 15,597 shares of DXCM stock, worth $1.25 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
15,597
Previous 7,068 120.67%
Holding current value
$1.25 Million
Previous $801,000 30.46%
% of portfolio
0.24%
Previous 0.15%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$64.0 - $116.06 $545,856 - $989,875
8,529 Added 120.67%
15,597 $1.05 Million
Q2 2024

Aug 13, 2024

BUY
$110.31 - $140.45 $779,671 - $992,700
7,068 New
7,068 $801,000
Q2 2023

Aug 11, 2023

BUY
$112.47 - $130.98 $260,480 - $303,349
2,316 New
2,316 $297,000
Q1 2022

May 10, 2022

SELL
$94.08 - $130.2 $41,207 - $57,027
-438 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$129.87 - $162.82 $56,883 - $71,315
438 New
438 $235,000
Q3 2020

Oct 29, 2020

SELL
$95.51 - $112.95 $77,267 - $91,376
-809 Closed
0 $0
Q2 2020

Jul 31, 2020

BUY
$62.68 - $105.34 $50,708 - $85,220
809 New
809 $328,000
Q2 2019

Jul 17, 2019

SELL
$27.84 - $38.92 $109,940 - $153,695
-3,949 Closed
0 $0
Q1 2019

Oct 17, 2019

BUY
$28.07 - $38.18 $110,848 - $150,772
3,949 New
3,949 $470,000
Q4 2018

Jan 15, 2019

SELL
$26.99 - $37.37 $131,954 - $182,701
-4,889 Closed
0 $0
Q3 2018

Oct 05, 2018

BUY
$23.35 - $36.72 $114,158 - $179,524
4,889 New
4,889 $699,000
Q4 2017

Jan 18, 2018

SELL
$11.12 - $15.38 $216,839 - $299,910
-19,500 Closed
0 $0
Q3 2017

Oct 23, 2017

BUY
$11.36 - $18.98 $221,520 - $370,110
19,500
19,500 $954,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Fox Run Management, L.L.C. Portfolio

Follow Fox Run Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Fox Run Management, L.L.C. with notifications on news.